Maximum androgen blockade in advanced prostate cancer

被引：0
|
作者：
Wirth, M [1 ]
机构：
[1] Univ Klinikum Dresden, Klin & Poliklin Urol, D-01307 Dresden, Germany
来源：
FORTSCHRITTE IN DIAGNOSTIK UND THERAPIE DES PROSTATAKARZINOMS | 1997年 / 5卷
关键词：
BILATERAL ORCHIECTOMY; CYPROTERONE-ACETATE; CONTROLLED TRIAL; FLUTAMIDE; COMBINATION; ZOLADEX; THERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：59 / 66
页数：8
相关论文
共 50 条
  • [31] Combined androgen blockade is the treatment of choice for patients with advanced prostate cancer: The argument for
    Debruyne, FMJ
    EUROPEAN UROLOGY, 1996, 29 : 34 - 36
  • [32] Twenty Years of Controversy Surrounding Combined Androgen Blockade for Advanced Prostate Cancer
    Moul, Judd W.
    CANCER, 2009, 115 (15) : 3376 - 3378
  • [33] Clinical outcomes of anti-androgen withdrawal and subsequent alternative anti-androgen therapy for advanced prostate cancer following failure of initial maximum androgen blockade
    Momozono, Hiroyuki
    Miyake, Hideaki
    Tei, Hiromoto
    Harada, Ken-Ichi
    Fujisawa, Masato
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (05) : 839 - 844
  • [34] Maximum androgen blockade in advanced prostate cancer: A meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens
    Caubet, JF
    Tosteson, TD
    Dong, EW
    Naylon, EM
    Whiting, GW
    Ernstoff, MS
    Ross, SD
    UROLOGY, 1997, 49 (01) : 71 - 78
  • [35] Alternative non-steroidal antiandrogen therapy for advanced prostate cancer that has relapsed after initial maximum androgen blockade
    Suzuki, H.
    Fujisawa, M.
    Matsumoto, T.
    Takeda, M.
    Usui, T.
    Matsuda, T.
    Ozono, S.
    Kumon, H.
    Ichikawa, T.
    Miki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer
    Ahmet Kiper
    Orhan Yiğitbası
    Abdurrahim Imamoglu
    Can Tuygun
    Celaleddin Turan
    International Urology and Nephrology, 2006, 38 : 571 - 576
  • [37] The prognostic importance of prostate specific antigen in the monitorisation of patients undergoing maximum androgen blockade for metastatic prostate cancer
    Kiper, Ahmet
    Yigitbasi, Orhan
    Imamoglu, Abdurrahim
    Tuygun, Can
    Turan, Celaleddin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (3-4) : 571 - 576
  • [38] Total androgen blockade questioned in prostate cancer
    不详
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1161 - 1161
  • [39] Androgen blockade in prostate cancer -: Authors' reply
    Dalesio, O
    van Tinteren, H
    Peto, R
    Clarke, M
    Schröder, FH
    LANCET, 2000, 356 (9226): : 341 - 342
  • [40] TOTAL ANDROGEN BLOCKADE FOR METASTATIC CANCER OF PROSTATE
    BELAND, G
    ELHILALLI, MM
    FRADET, Y
    LAROCHE, B
    RAMSEY, EW
    TRACHTENBERG, J
    VENNER, PN
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (08): : 1233 - 1233
12345